Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 237-239, October 2006

An audit of the use and complications of glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention against national UK standards

Trent Cardiac Centre, City Hospital Campus, Nottingham University Hospitals, NHS Trust, Nottingham NG5 1PB, UK

Received 20 May 2006; received in revised form 18 July 2006; accepted 18 July 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1553-8389(06)00186-2

doi:10.1016/j.carrev.2006.07.005

Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 237-239, October 2006

Article Tools

* Image Usage & Resolution